These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36629948)

  • 1. Expert consensus on vaccination in patients with inflammatory bowel disease in Japan.
    Ishige T; Shimizu T; Watanabe K; Arai K; Kamei K; Kudo T; Kunisaki R; Tokuhara D; Naganuma M; Mizuochi T; Murashima A; Inoki Y; Iwata N; Iwama I; Koinuma S; Shimizu H; Jimbo K; Takaki Y; Takahashi S; Cho Y; Nambu R; Nishida D; Hagiwara SI; Hikita N; Fujikawa H; Hosoi K; Hosomi S; Mikami Y; Miyoshi J; Yagi R; Yokoyama Y; Hisamatsu T
    J Gastroenterol; 2023 Feb; 58(2):135-157. PubMed ID: 36629948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
    Jones JL; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Benchimol EI
    Gastroenterology; 2021 Aug; 161(2):681-700. PubMed ID: 34334167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
    Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL
    Gastroenterology; 2021 Aug; 161(2):669-680.e0. PubMed ID: 33617891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations of the Spanish Group on Crohn's Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patients.
    Ferreiro-Iglesias R; Piqueras M; Ricart E; Sempere L; Roca M; Martín de Carpi J; Benítez O; Zabana Y; Mañosa M; Rodríguez-Moranta F; Barreiro-de Acosta M;
    Gastroenterol Hepatol; 2022 Dec; 45(10):805-818. PubMed ID: 35577225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
    Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
    Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the vaccination in inflammatory bowel disease.
    Carrera E; Manzano R; Garrido E
    World J Gastroenterol; 2013 Mar; 19(9):1349-53. PubMed ID: 23538553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.
    Nakase H; Uchino M; Shinzaki S; Matsuura M; Matsuoka K; Kobayashi T; Saruta M; Hirai F; Hata K; Hiraoka S; Esaki M; Sugimoto K; Fuji T; Watanabe K; Nakamura S; Inoue N; Itoh T; Naganuma M; Hisamatsu T; Watanabe M; Miwa H; Enomoto N; Shimosegawa T; Koike K
    J Gastroenterol; 2021 Jun; 56(6):489-526. PubMed ID: 33885977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
    Jones JL; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Benchimol EI
    J Can Assoc Gastroenterol; 2021 Aug; 4(4):e72-e91. PubMed ID: 34476339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ideal vaccination strategy in inflammatory bowel disease].
    Lee CK
    Korean J Gastroenterol; 2015 Mar; 65(3):159-64. PubMed ID: 25797379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles vaccination and inflammatory bowel disease: controversy laid to rest?
    Davis RL; Bohlke K
    Drug Saf; 2001; 24(13):939-46. PubMed ID: 11735650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates on vaccinating the inflammatory bowel disease patient.
    Zullow S; Farraye FA
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):229-239. PubMed ID: 30791761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination strategies in pediatric inflammatory bowel disease.
    Dipasquale V; Romano C
    Vaccine; 2017 Oct; 35(45):6070-6075. PubMed ID: 28967524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-Preventable Diseases in Hospitalized Patients With Inflammatory Bowel Disease: A Nationwide Cohort Analysis.
    Vinsard DG; Wakefield D; Vaziri H; Karagozian R
    Inflamm Bowel Dis; 2019 Nov; 25(12):1966-1973. PubMed ID: 31067308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet's disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants.
    Watanabe K; Tanida S; Inoue N; Kunisaki R; Kobayashi K; Nagahori M; Arai K; Uchino M; Koganei K; Kobayashi T; Takeno M; Ueno F; Matsumoto T; Mizuki N; Suzuki Y; Hisamatsu T
    J Gastroenterol; 2020 Jul; 55(7):679-700. PubMed ID: 32377946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
    Classen JM; Muzalyova A; Nagl S; Fleischmann C; Ebigbo A; Römmele C; Messmann H; Schnoy E
    Dig Dis; 2022; 40(6):719-727. PubMed ID: 34915480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.
    Siegel CA; Melmed GY; McGovern DP; Rai V; Krammer F; Rubin DT; Abreu MT; Dubinsky MC; ;
    Gut; 2021 Apr; 70(4):635-640. PubMed ID: 33472895
    [No Abstract]   [Full Text] [Related]  

  • 20. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
    Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL
    J Can Assoc Gastroenterol; 2021 Aug; 4(4):e59-e71. PubMed ID: 34476338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.